These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 33755373)

  • 1. BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
    Benenson S; Oster Y; Cohen MJ; Nir-Paz R
    N Engl J Med; 2021 May; 384(18):1775-1777. PubMed ID: 33755373
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: preliminary results.
    Zee JST; Lai KTW; Ho MKS; Leung ACP; Chan QWL; Ma ESK; Lee KH; Lau CC; Yung RWH
    Hong Kong Med J; 2021 Aug; 27(4):312-313. PubMed ID: 34413252
    [No Abstract]   [Full Text] [Related]  

  • 3. Audio Interview: A New mRNA Vaccine.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jun; 384(25):e109. PubMed ID: 34161714
    [No Abstract]   [Full Text] [Related]  

  • 4. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.
    Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A
    Front Immunol; 2021; 12():657711. PubMed ID: 33777055
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.
    Bugatti S; De Stefano L; Balduzzi S; Greco MI; Luvaro T; Cassaniti I; Bogliolo L; Mazzucchelli I; D'Onofrio B; di Lernia M; Mauric E; Lilleri D; Baldanti F; Manzo A; Montecucco C
    Ann Rheum Dis; 2021 Dec; 80(12):1635-1638. PubMed ID: 34172502
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021.
    Abu Jabal K; Ben-Amram H; Beiruti K; Batheesh Y; Sussan C; Zarka S; Edelstein M
    Euro Surveill; 2021 Feb; 26(6):. PubMed ID: 33573712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
    Abu-Raddad LJ; Chemaitelly H; Butt AA;
    N Engl J Med; 2021 Jul; 385(2):187-189. PubMed ID: 33951357
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.
    Dimopoulou D; Vartzelis G; Dasoula F; Tsolia M; Maritsi D
    Ann Rheum Dis; 2022 Apr; 81(4):592-593. PubMed ID: 34844930
    [No Abstract]   [Full Text] [Related]  

  • 9. Relief and worry for immune-suppressed people.
    Couzin-Frankel J
    Science; 2021 Apr; 372(6541):443-444. PubMed ID: 33926929
    [No Abstract]   [Full Text] [Related]  

  • 10. Association Between Exposure Characteristics and the Risk for COVID-19 Infection Among Health Care Workers With and Without BNT162b2 Vaccination.
    Oster Y; Benenson S; Yochi Harpaz L; Buda I; Nir-Paz R; Strahilevitz J; Cohen MJ
    JAMA Netw Open; 2021 Sep; 4(9):e2125394. PubMed ID: 34468758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?
    Van Dreden P; Fareed J; Elalamy I; Gerotziafas G
    Clin Appl Thromb Hemost; 2021; 27():10760296211033906. PubMed ID: 34689575
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccines for patients with haematological conditions.
    Sun C; Pleyer C; Wiestner A
    Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
    [No Abstract]   [Full Text] [Related]  

  • 14. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 15. Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
    Rubin EJ; Baden LR; Abraham J; Morrissey S
    N Engl J Med; 2021 Mar; 384(10):e48. PubMed ID: 33704945
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.
    García-Grimshaw M; Ceballos-Liceaga SE; Hernández-Vanegas LE; Núñez I; Hernández-Valdivia N; Carrillo-García DA; Michel-Chávez A; Galnares-Olalde JA; Carbajal-Sandoval G; Del Mar Saniger-Alba M; Carrillo-Mezo RA; Fragoso-Saavedra S; Espino-Ojeda A; Blaisdell-Vidal C; Mosqueda-Gómez JL; Sierra-Madero J; Pérez-Padilla R; Alomía-Zegarra JL; López-Gatell H; Díaz-Ortega JL; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
    Clin Immunol; 2021 Aug; 229():108786. PubMed ID: 34147649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Johnson & Johnson Vaccine for COVID-19.
    Livingston EH; Malani PN; Creech CB
    JAMA; 2021 Apr; 325(15):1575. PubMed ID: 33646285
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19: An unprecedented challenge and an opportunity for change.
    Kwon YJ; Forthal D
    Adv Drug Deliv Rev; 2021 Apr; 171():48-49. PubMed ID: 33524417
    [No Abstract]   [Full Text] [Related]  

  • 19. How COVID unlocked the power of RNA vaccines.
    Dolgin E
    Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
    Peter J
    S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.